Category: Administering Epipen

Administering Epipen – Administering.net

PRESS RELEASE: Laura Trott MP calls for an end to under 18’s receiving Botox and cosmetic fillers

Conservative MP for Sevenoaks and Swanley, Laura Trott, is today introducing a Private Members Bill which would ban under 18’s from being able to receive cosmetic Botox or fillers. The Bill, entitled, the “Botulinum Toxin and Cosmetic Fillers (Children) Bill” will also require a doctor, registered medical practitioner, or a health professional to administer such procedures where there is a...

READ MORE PRESS RELEASE: Laura Trott MP calls for an end to under 18’s receiving Botox and cosmetic fillers

Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting

IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020. The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows. Oral presentations include: Patient...

READ MORE Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting

Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year

“As a physician in practice for nearly two decades, I have many long-standing patients who come in for retreatment with neuromodulators every three to four months. In the DREAM study, we were interested in evaluating patient satisfaction with a regimen in which Dysport was administered on a twice-yearly schedule,” said Joel L. Cohen, M.D.**, a board-certified and fellowship-trained dermatologist and...

READ MORE Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year

BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation

DUBLIN, Dec. 16, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN[1]) is commemorating today the beginning of the 30th anniversary celebration for BOTOX® this year with the ringing of the New York Stock Exchange opening bell. Over the past 30 years, more than 100 million vials of BOTOX® and BOTOX® Cosmetic have been manufactured worldwide, providing a trusted and effective treatment option...

READ MORE BOTOX® (onabotulinumtoxinA) Celebrates 30 Years of Endless Innovation